Stock Analysis
Clarivate Plc (CLVT) Stock Analysis
Clarivate Plc (CLVT) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Clarivate Plc (CLVT) currently has an AIQ Score of 54/100, indicating a neutral setup. Value is the strongest factor at 75/100. Risk is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CLVT at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $2.07 |
| AIQ Score | 54/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $1.3B |
| P/E Ratio | 2.76 |
| Forward P/E | — |
| EPS | -$0.42 |
| Revenue TTM | $587.3M |
| Dividend Yield | 0.00% |
| Beta | 1.39 |
| Volume | 2.68M |
| 52-week range | $1.66-$4.54 |
| RSI 14 | 62.5 |
| 50-Day SMA | $2.11 |
| 200-Day SMA | $2.56 |
| Analyst Price Target | $2.25 |
| Next Earnings | Nov 4, 2026 |
CLVT
OverviewCLVT Stock Analysis Summary
Clarivate Plc (CLVT) currently has an AIQ Score of 54/100, indicating a neutral setup. Value is the strongest factor at 75/100. Risk resilience is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CLVT has AIQ Score of 54/100 with Value base of 75/100 and fading Risk resilience at 31/100. Wait for component alignment before adding exposure.
Value (75/100) leads while Risk resilience (31/100) lags. This cross-factor spread creates entry timing uncertainty.
Technology · -3.72% stock move · CLVT classified in Information Technology Services.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CLVT Bullish or Bearish Right Now?
CLVT currently has a neutral overall setup. Value is the strongest factor at 75/100, while Risk Resilience is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Analyst target implies +8.70% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (25 vs 12).
- - Risk Resilience is weak at 31/100.
- - Price is -19.21% below its 200-day SMA.
Current Consensus
CLVT's Technical Analysis Consensus is currently Buy, with 25 buy, 8 neutral, and 12 sell votes. CLVT's 14-day RSI is 62.5, which places the stock in a constructive momentum range. CLVT's beta is 1.39, indicating greater market sensitivity than the broad market.
What Changed in CLVT?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the CLVT Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CLVT Decision Framework
Public evidence layers, setup checks, and risk context for Clarivate Plc.
Clarivate Plc (CLVT) Stock Analysis
Clarivate Plc has an AIQ Score of 54/100 in a Neutral regime. Value is strongest at 75/100. Beta is 1.39, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CLVT is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that value leads at 75/100 while risk lags at 31/100. |
| Factor Evidence | Momentum 52/100 · Value 75/100 · Quality 46/100 · Risk 31/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 75/100.
Momentum is 52/100 and RSI (14) is 62.5.
CLVT is in a Neutral regime at 54/100.
Risk factor is 31/100 with beta 1.39 and annual volatility 74.67%.
Current conflict: value leads at 75/100 while risk lags at 31/100.
CLVT Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CLVT Fundamentals
CLVT valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CLVT Technical Analysis
CLVT technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CLVT Stock Catalysts
Track CLVT earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CLVT Dividend Analysis
CLVT dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CLVT Financial Data
CLVT revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CLVT Risk Analysis
CLVT volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CLVT Stock News
CLVT stock news, market tone, recent headlines, and catalyst context.
CLVT vs Life Sciences / Tools / CRO Peers
Current peer cohort: CLVT · DHR · EFX · EXAS · ILMN. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CLVT Current stock | 54/100 | 75/100 | 52/100 | 31/100 | -0.66 | 74.67% | Current |
| DHR Danaher | 53/100 | 37/100 | 63/100 | 59/100 | 0.17 | 31.53% | CLVT vs DHR |
| EFX Equifax | 44/100 | 53/100 | 37/100 | 37/100 | -0.69 | 39.25% | CLVT vs EFX |
| EXAS Exact Sciences | 46/100 | 37/100 | — | 67/100 | 2.03 | 43.05% | CLVT vs EXAS |
| ILMN Illumina | 56/100 | 26/100 | 73/100 | 42/100 | 1.82 | 48.56% | CLVT vs ILMN |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 4, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 5, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CLVT
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CLVT
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CLVT Stock FAQ
What is CLVT stock price today?
Clarivate Plc's current stock price is $2.07. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CLVT bullish or bearish right now?
CLVT's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CLVT's market cap?
CLVT's market cap is $1.3B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CLVT's current P/E ratio?
CLVT's current P/E ratio is 2.76 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CLVT's RSI?
CLVT's 14-day RSI is 62.5 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CLVT above its 50-day and 200-day moving averages?
CLVT is -1.97% from its 50-day SMA and -19.21% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CLVT's next earnings date?
CLVT's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CLVT pay a dividend?
CLVT's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.